|
|
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
Subjects:
“...Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy...”Published 2010
AHRQ Technology Assessment Program
|
|
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
Subjects:
“...Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy...”Published 2010
AHRQ Technology Assessment Program
|
|
by Trikalinos, Thomas A., Raman, Gowri, Kupelnick, Bruce, Chew, Priscilla W.
Published 2006
“...Concurrent treatment with ø-agonists and/or hormonal treatments and/or new therapies (e.g., spiriva...”Published 2006
AHRQ Technology Assessment Program
|
|
by Trikalinos, Thomas A., Raman, Gowri, Kupelnick, Bruce, Chew, Priscilla W.
Published 2006
“...Concurrent treatment with ø-agonists and/or hormonal treatments and/or new therapies (e.g., spiriva...”Published 2006
AHRQ Technology Assessment Program